tiprankstipranks
Compugen initiated with an Outperform at Oppenheimer
PremiumThe FlyCompugen initiated with an Outperform at Oppenheimer
22d ago
AMD downgraded, Nike upgraded: Wall Street’s top analyst calls
Premium
The Fly
AMD downgraded, Nike upgraded: Wall Street’s top analyst calls
25d ago
Gilead upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Gilead upgraded to Overweight from Equal Weight at Morgan Stanley
25d ago
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
PremiumThe FlyCapricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
2M ago
Gilead granted Breakthrough Therapy Designation for Trodelvy by FDA
Premium
The Fly
Gilead granted Breakthrough Therapy Designation for Trodelvy by FDA
2M ago
Gilead, Terray Therapeutics announce research collaboration
Premium
The Fly
Gilead, Terray Therapeutics announce research collaboration
2M ago
Gilead’s Kite announces results from 5-year follow-up study of Yescarta in NHL
PremiumThe FlyGilead’s Kite announces results from 5-year follow-up study of Yescarta in NHL
2M ago
Gilead’s Kite announces results from 5-year follow-up study of Yescarta in NHL
Premium
The Fly
Gilead’s Kite announces results from 5-year follow-up study of Yescarta in NHL
2M ago
Gilead price target raised to $115 from $105 at Oppenheimer
Premium
The Fly
Gilead price target raised to $115 from $105 at Oppenheimer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100